Recent studies have shown that the expression of HLA-B is inhibited in esophageal squamous cell carcinomas (ESCC) by hypermethylation, a phenomenon that was reversed by treatment with decitabine7. This evidence concerns the gene HLA-B and esophageal squamous cell carcinoma.